TORONTO, Dec. 13 /CNW Telbec/ - Bayer Inc. was honoured today by Health
Partners International of Canada (HPIC) for contributing more than $10 million
in medical aid since 1995 and was further recognized for its ongoing
commitment to provide life-saving products to patients in developing countries
"Bayer's ongoing commitment to help the people of the developing world
with essential medicines is to be strongly commended," said John Kelsall,
President, Health Partners International of Canada. "This $10 million
milestone is indicative of Bayer's continued dedication to improving people's
In 2007 alone, Bayer products, valued at close to $2 million, were
distributed to patients in 55 countries and played an important role in HPIC's
Afghanistan medical aid program.
"Bayer Inc. is very proud to partner with HPIC," said Philip Blake,
President & CEO, Bayer Inc. "We are deeply committed to providing patients
with the best medicine and continue to invest in the research and development
of innovative products that address high unmet medical needs.
Bayer's contribution to HPIC includes providing medications that are a
part of the organization's Physician Travel Pack (PTP). PTPs are prepared for
use by Canadian health-care professionals travelling to work in clinics in the
developing world. Each PTP has a portable selection of basic medicines and
supplies for use in the field. All PTPs contain at least one Bayer product,
such as Aspirin(R) (ASA), Adalat(R) XL (R) (nifedipine), Biltricide(R)
(praziquantel), Cipro(R) (ciprofloxacin), and One A Day(R) and Flintstones(R)
"Vitamins are one of the most important items in the Physician Travel
Pack," said Gail Perry, a nurse who has been volunteering in the Dominican
Republic over the past 15 years. "The people are so undernourished that
vitamins are the first line of treatment to build up their systems so we can
treat them further."
Over its 12-year partnership with HPIC, Bayer has provided life-saving
products to patients in more than 100 countries including Afghanistan, the
Democratic Republic of the Congo, the Dominican Republic, Haiti, Lebanon,
North Korea and Peru.
About Bayer Inc.
Bayer Inc. (Bayer) is a Canadian subsidiary of Bayer AG, an international
research-based group with core businesses in health care, crop science, and
innovative materials. Headquartered in Toronto, Ontario, Bayer Inc. operates
the Bayer Group's HealthCare and MaterialScience businesses in Canada. Bayer
CropScience Inc., headquartered in Calgary, Alberta operates as a separate
legal entity in Canada. Together, the companies play a vital role in improving
the quality of life for Canadians - producing products that fight diseases,
protecting crops and animals, and developing high-performance materials for
applications in numerous areas of daily life. Canadian Bayer facilities
include the Toronto headquarters and offices in Ottawa and Calgary. Bayer Inc.
has approximately 1,000 employees across Canada and had sales of over
$910 million CDN in 2006. Globally, the Bayer Group had sales of over
28 billion Euro in 2006. Bayer Inc. invested approximately $47 million CDN in
research and development in 2006. Worldwide, the Bayer Group spends the
equivalent of over 2 billion Euro in 2006 in R&D.
About Health Partners International of Canada (HPIC)
HPIC is a medical aid organization dedicated to improving access to
health care and medicine in the developing world. Since 1990, HPIC has
provided medical aid worth more than $250 million to people in 116 countries.
For further information:
For further information: Bayer: Emily Hanft, Business Communications
Specialist, Bayer Inc., (416) 240-5434, email@example.com; HPIC: Marg
Buchanan, Manager, Media Relations, (514) 695-0007, (514) 402-2270 (cell),